Sinopharm
1099.HK
#2571
Rank
โ‚น668.74 B
Marketcap
โ‚น214.30
Share price
0.17%
Change (1 day)
10.80%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น219.39 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น219.39 Billion a decrease over its 2023 earnings that were of โ‚น304.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น219.39 B-27.86%
2023โ‚น304.13 B-0.73%
2022โ‚น306.37 B-1.72%
2021โ‚น311.72 B11.7%
2020โ‚น279.06 B18.44%
2019โ‚น235.61 B10.85%
2018โ‚น212.55 B3.05%
2017โ‚น206.26 B36.48%
2016โ‚น151.13 B7.11%
2015โ‚น141.10 B12.38%
2014โ‚น125.56 B25.05%
2013โ‚น100.41 B22.54%
2012โ‚น81.94 B35.43%
2011โ‚น60.50 B52.24%
2010โ‚น39.74 B30.99%
2009โ‚น30.34 B60.59%
2008โ‚น18.89 B48.29%
2007โ‚น12.74 B123.29%
2006โ‚น5.70 B